Alcanza Clinical Research’s Post

On #WorldParkinsonsDay today, learn more about what life is like living with this disease through real experiences shared from this patient community. We continue to learn from patients and their families about their experiences living with Parkinson’s disease.     Jazz is advancing research in our neuroscience pipeline bit.ly/3UodckV including a Phase 2 study for those living with Parkinson’s disease tremor (U.S. only bit.ly/4aNnBMa). 

As we welcome 2024, reflect on Neuro Central’s highlights and top-performing content of 2023. Explore various topics, including Alzheimer’s, multiple sclerosis and epilepsy in this roundup article by Annie Coulson >>> https://bit.ly/41PF3MA

🧠 September is World Alzheimer's Month, a time to raise awareness about the impact of Alzheimer's disease and the importance of research in finding a cure. 💜 Did you know that Alzheimer's is a progressive brain disorder that affects millions worldwide? It not only challenges the individuals living with it but also their families and caregivers. 🔬 Research is the key to understanding Alzheimer's better, developing effective treatments, and ultimately finding a cure. Every step forward in our knowledge brings us closer to a world without Alzheimer's. 💪 Those who are able to volunteer, can help play their part in the fight against Alzheimer's by participating in clinical trials. By joining research studies, you can directly contribute to finding a cure. Together, we can make a difference 💜 #WorldAlzheimersMonth #ResearchMatters #GlasgowMemoryClinic #NeuroClin

June is Alzheimer’s and Brain Awareness Month, a time to unite in the fight against the brain disease that affects millions of lives worldwide. Understanding the impact of Alzheimer’s and related dementias is crucial in our journey towards creating effective treatments. This month, let's amplify the conversation around brain health, share the latest research breakthroughs, and support those affected by Alzheimer’s. Together, we can pave the way for a future without Alzheimer's. #AlzheimersAndBrainAwarenessMonth #EndAlzheimers

November is National Alzheimer’s Disease Awareness Month. 🧠❤️ Six million Americans suffer from Alzheimer’s disease, and that number is projected to soar to 14 million by 2050. The Keck School has four world-renowned research centers and institutes focused on this devastating disease. Taking a multi-angled approach – from basic research on the earliest molecular changes that lead to cognitive decline to clinical trials of innovative treatments to slow or prevent the disease’s progression – the Keck School of Medicine of USC is at the forefront of Alzheimer’s research. Learn more about our Alzheimer's research: keck.usc.edu/alzheimers #alzheimersawareness #alzheimersawarenessmonth

Today is World Alzheimer's Day, a day to remember and honor the millions of individuals and families impacted by Alzheimer's. Together, we can positively impact the lives of those affected by this disease. Owlstone is working on applying our Breath Biopsy technology to combat neurological diseases, including Alzheimer's. You can find out more about the neurological applications of breath analysis below 👇 https://ow.ly/HVhf50P1o8a #WorldAlzheimer’sDay2023

Webinar: Shifting the Paradigm - A New Era of Alzheimer's Clinical Trials Yesterday, June 24th, we held webinar for Alzheimer's and Brain Awareness Month featuring Dani Cabral, MD, IMA Phoenix Principal Investigator and Alzheimer's Key Opinion Leader, and Shayne Barbour-Ladak MD CMD, IMA Albuquerque Principal Investigator and graduate of the Harvard program in Palliative Care Education and Practice.   In "Shifting the Paradigm: A New Era of Alzheimer's Clinical Trials," they discussed the unique aspects of conducting Alzheimer’s research from the disease complexities to patient screening and the factors that contribute to a successful study.   If you're interested in accessing the webinar, please reach out to our Business Development team to get the link [email protected] #AlzheimersResearch #ClinicalTrials #ClinicalResearch #AlzheimersAndBrainAwarenessMonth

🌟 Exciting Progress in Alzheimer's Research! 🌟 In a recent interview on CNYCentral WSTM NBC3, WTVH CBS5 & CW6, Dr. Joseph Palumbo, MD, LFAPA, MACPsych, Chief Medical Officer of BioVie Inc., shared groundbreaking insights into their research on Alzheimer's treatment. Did you know that Alzheimer's affects over 6 million Americans and still has no cure? It's a challenging problem, but BioVie is making a difference. Dr. Palumbo discussed NE3107, a potential game-changer that's currently in Phase 3 clinical trials. Early results are promising, showing potential benefits for Alzheimer's patients. With the prevalence of Alzheimer's increasing, innovative solutions like NE3107 are urgently needed. BioVie's dedication to finding a treatment is evident, and their progress is remarkable. Let's support BioVie's mission to improve the lives of millions affected by Alzheimer's. Check out the interview for more details and join the fight against this devastating disease. 📚 Watch the video here: https://lnkd.in/g6P2kq4n #Alzheimers #BioVie #Research #Innovation